Table 2.
Best response rate by mRCC histology in patients with evaluable response (n = 21).
Clear cell | Non-Clear cell | Total | |||
---|---|---|---|---|---|
(n = 11) | (n = 10) | (n = 21) | |||
Papillary | Unclassified | Translocation | |||
(n = 7*) | (n = 2) | (n = 1) | |||
ORR | 6 (29%) | 1 (5%) | - | - | 7 (33%) |
CR | 1 (5%) | 1 (5%) | - | - | 2 (10%) |
PR | 5 (24%) | - | - | - | 5 (24%) |
SD | 2 (10%) | 3 (14%) | 1 (5%) | - | 6 (29%) |
PD | 3 (14%) | 3 (14%) | 1 (5%) | 1 (5%) | 8 (38%) |
This group includes three patients with clear cell component.